Nexvet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Nexvet and buy or sell other stocks, ETFs, and their options commission-free!

About NVET

Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. 

CEO
Mark Heffernan, PhD
CEOMark Heffernan, PhD
Employees
Employees
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2014
Founded2014
Employees
Employees

NVET Key Statistics

Market cap
80.01M
Market cap80.01M
Price-Earnings ratio
-3.83
Price-Earnings ratio-3.83
Dividend yield
Dividend yield
Average volume
20.08K
Average volume20.08K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.76
52 Week high$6.76
52 Week low
$2.75
52 Week low$2.75

Stock Snapshot

Nexvet(NVET) stock is priced at $6.72, giving the company a market capitalization of 80.01M. It carries a P/E multiple of -3.83.

Nexvet(NVET) stock opened on 2025-12-08 at —. The price climbed to — and dipped to —.

Nexvet(NVET) shares are trading with a volume of 0, against a daily average of 20.08K.

During the past year, Nexvet(NVET) stock moved between $2.75 at its lowest and $6.76 at its peak.

During the past year, Nexvet(NVET) stock moved between $2.75 at its lowest and $6.76 at its peak.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.